Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects?
A team of Cleveland Clinic researchers is exploring new antidotes against fentanyl overdose that eliminate the respiratory depression effects of opioids without interfering with their other effects.